Profile · INSIDERData sourcesSEC FORM 42m ago
HOUSE PTR2m ago
SEC 13F2m ago
ROBINHOOD CHAIN2m ago
Public companyOlema Pharmaceuticals, Inc.
OLMACIK 0001750284
Price$6.76
1 year-17.6%
Disclosed transactions45
Buys / sells0 / 17
Max Insider Score48
Connections with evidence10
OLMA · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 9 | OJO'Byrne JasonCHIEF FINANCIAL OFFICER | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 650.0K sh | Sep 1, 2026 | Sep 2, 2026 |
| 15 | HGHrustanovic GorjanDirector | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 29.5K sh | Jun 18, 2026 | Jun 23, 2026 traded Jun 18, 2026 | +5d | SEC FORM 4 | |
| 15 | | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 29.5K sh | Jun 18, 2026 | Jun 23, 2026 traded Jun 18, 2026 | +5d | SEC FORM 4 | |
| 11 | | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 29.5K sh | Jun 18, 2026 | Jun 23, 2026 traded Jun 18, 2026 | +5d | SEC FORM 4 | |
| 9 | | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 24.1K sh | Apr 28, 2026 | Apr 29, 2026 traded Apr 28, 2026 | +1d | SEC FORM 4 | |
| 9 | | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 2,911 sh | Apr 28, 2026 | Apr 29, 2026 traded Apr 28, 2026 | +1d | SEC FORM 4 | |
| 31 | ALAustin Sasha LuVP of Finance and Controller | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 11.7K sh | Feb 2, 2026 | Feb 17, 2026 traded Feb 2, 2026 | +15d | SEC FORM 4 | |
| 19 | ALAustin Sasha LuVP of Finance and Controller | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 29.3K sh | Feb 2, 2026 | Feb 17, 2026 traded Feb 2, 2026 | +15d | SEC FORM 4 | |
| 2 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 250.0K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC FORM 4 | |
| 5 | ZNZojwalla NaseemCHIEF MEDICAL OFFICER | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 106.3K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC FORM 4 | |
| 9 | BSBohen SeanDirector, PRESIDENT AND CEO | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 275.0K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC FORM 4 | |
| 2 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 106.3K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC FORM 4 | |
| 5 | ZNZojwalla NaseemCHIEF MEDICAL OFFICER | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 250.0K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC FORM 4 | |
| 9 | BSBohen SeanDirector, PRESIDENT AND CEO | OLMAOlema Pharmaceuticals, Inc. Grant or award | A | — 850.0K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC FORM 4 | |
| 33 | | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $269K 10.0K sh | Jan 20, 2026 | Jan 21, 2026 traded Jan 20, 2026 | +1d | SEC FORM 4 | |
| 30 | | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $102K 3,489 sh | Jan 14, 2026 | Jan 16, 2026 traded Jan 14, 2026 | +2d | SEC FORM 4 | |
| 44 | KCKovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF. | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $2.87M 100.0K sh | Jan 15, 2026 | Jan 15, 2026 traded Jan 15, 2026 | +0d | SEC FORM 4 | |
| 34 | KCKovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF. | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $107K 3,822 sh | Jan 13, 2026 | Jan 15, 2026 traded Jan 13, 2026 | +2d | SEC FORM 4 | |
| 37 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $283K 10.0K sh | Jan 12, 2026 | Jan 14, 2026 traded Jan 12, 2026 | +2d | SEC FORM 4 | |
| 40 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $1.37M 49.8K sh | Jan 13, 2026 | Jan 14, 2026 traded Jan 13, 2026 | +1d | SEC FORM 4 | |
| 12 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Option exercise | M | $244K 50.0K sh | Jan 13, 2026 | Jan 14, 2026 traded Jan 13, 2026 | +1d | SEC FORM 4 | |
| 27 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $5,698 200 sh | Jan 13, 2026 | Jan 14, 2026 traded Jan 13, 2026 | +1d | SEC FORM 4 | |
| 30 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $429K 15.0K sh | Jan 14, 2026 | Jan 14, 2026 traded Jan 14, 2026 | +0d | SEC FORM 4 | |
| 17 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Option exercise | M | — 50.0K sh | Jan 13, 2026 | Jan 14, 2026 traded Jan 13, 2026 | +1d | SEC FORM 4 | |
| 37 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $1.01M 35.0K sh | Jan 14, 2026 | Jan 14, 2026 traded Jan 14, 2026 | +0d | SEC FORM 4 | |
| 2 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Option exercise | M | — 50.0K sh | Jan 14, 2026 | Jan 14, 2026 traded Jan 14, 2026 | +0d | SEC FORM 4 | |
| 9 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Option exercise | M | $244K 50.0K sh | Jan 14, 2026 | Jan 14, 2026 traded Jan 14, 2026 | +0d | SEC FORM 4 | |
| 12 | BSBohen SeanDirector, President and CEO | OLMAOlema Pharmaceuticals, Inc. Gift | G | — 8,500 sh | Dec 26, 2025 | Dec 30, 2025 traded Dec 26, 2025 | +4d | SEC FORM 4 | |
| 40 | | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $82K 2,881 sh | Dec 22, 2025 | Dec 29, 2025 traded Dec 22, 2025 | +7d | SEC FORM 4 | |
| 12 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Gift | G | — 9,000 sh | Dec 19, 2025 | Dec 23, 2025 traded Dec 19, 2025 | +4d | SEC FORM 4 | |
| 19 | ZNZojwalla NaseemChief Medical Officer | OLMAOlema Pharmaceuticals, Inc. Option exercise | M | $653K 42.8K sh | Dec 22, 2025 | Dec 23, 2025 traded Dec 22, 2025 | +1d | SEC FORM 4 | |
| 8 | ZNZojwalla NaseemChief Medical Officer | OLMAOlema Pharmaceuticals, Inc. Option exercise | M | $50K 7,182 sh | Dec 22, 2025 | Dec 23, 2025 traded Dec 22, 2025 | +1d | SEC FORM 4 | |
| 13 | ZNZojwalla NaseemChief Medical Officer | OLMAOlema Pharmaceuticals, Inc. Option exercise | M | — 50.0K sh | Dec 23, 2025 | Dec 23, 2025 traded Dec 23, 2025 | +0d | SEC FORM 4 | |
| 17 | ZNZojwalla NaseemChief Medical Officer | OLMAOlema Pharmaceuticals, Inc. Option exercise | M | — 40.0K sh | Dec 19, 2025 | Dec 23, 2025 traded Dec 19, 2025 | +4d | SEC FORM 4 | |
| 23 | ZNZojwalla NaseemChief Medical Officer | OLMAOlema Pharmaceuticals, Inc. Option exercise | M | $351K 50.0K sh | Dec 23, 2025 | Dec 23, 2025 traded Dec 23, 2025 | +0d | SEC FORM 4 | |
| 44 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $1.33M 43.7K sh | Dec 19, 2025 | Dec 23, 2025 traded Dec 19, 2025 | +4d | SEC FORM 4 | |
| 48 | ZNZojwalla NaseemChief Medical Officer | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $2.80M 100.0K sh | Dec 22, 2025 | Dec 23, 2025 traded Dec 22, 2025 | +1d | SEC FORM 4 | |
| 41 | ZNZojwalla NaseemChief Medical Officer | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $374K 12.9K sh | Dec 19, 2025 | Dec 23, 2025 traded Dec 19, 2025 | +4d | SEC FORM 4 | |
| 48 | ZNZojwalla NaseemChief Medical Officer | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $1.60M 57.1K sh | Dec 19, 2025 | Dec 23, 2025 traded Dec 19, 2025 | +4d | SEC FORM 4 | |
| 23 | ZNZojwalla NaseemChief Medical Officer | OLMAOlema Pharmaceuticals, Inc. Option exercise | M | $610K 40.0K sh | Dec 19, 2025 | Dec 23, 2025 traded Dec 19, 2025 | +4d | SEC FORM 4 | |
| 31 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $34K 1,225 sh | Dec 19, 2025 | Dec 23, 2025 traded Dec 19, 2025 | +4d | SEC FORM 4 | |
| 5 | ZNZojwalla NaseemChief Medical Officer | OLMAOlema Pharmaceuticals, Inc. Option exercise | M | — 7,182 sh | Dec 22, 2025 | Dec 23, 2025 traded Dec 22, 2025 | +1d | SEC FORM 4 | |
| 48 | ZNZojwalla NaseemChief Medical Officer | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $2.75M 99.5K sh | Dec 23, 2025 | Dec 23, 2025 traded Dec 23, 2025 | +0d | SEC FORM 4 | |
| 17 | ZNZojwalla NaseemChief Medical Officer | OLMAOlema Pharmaceuticals, Inc. Option exercise | M | — 42.8K sh | Dec 22, 2025 | Dec 23, 2025 traded Dec 22, 2025 | +1d | SEC FORM 4 | |
| 34 | MCMyles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $190K 6,046 sh | Dec 19, 2025 | Dec 23, 2025 traded Dec 19, 2025 | +4d | SEC FORM 4 | |
VP of Finance and Controller · Feb 17, 2026
Bohen SeanDirector, President and CEO · Dec 30, 2025